InsiderTrades.com logo
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

Donald Steinberg Biography and Net Worth

Major Shareholder of Electromedical Technologies
  • Phone
  • Website


Mr. Donald Steinberg is the Major Shareholder of Electromedical Technologies.

What is Donald J. Steinberg's net worth?

The estimated net worth of Donald J. Steinberg is at least $276,642.87 as of August 28th, 2017. Mr. Steinberg owns 553,285,748 shares of Electromedical Technologies stock worth more than $276,643 as of April 19th. This net worth approximation does not reflect any other assets that Mr. Steinberg may own. Learn More about Donald J. Steinberg's net worth.

How do I contact Donald J. Steinberg?

The corporate mailing address for Mr. Steinberg and other Electromedical Technologies executives is 16561 North 92nd Street, Suit 101, Scottsdale, AZ 85260, United States. Electromedical Technologies can also be reached via phone at 888-880-7888. Learn More on Donald J. Steinberg's contact information.

Has Donald J. Steinberg been buying or selling shares of Electromedical Technologies?

Donald J. Steinberg has not been actively trading shares of Electromedical Technologies in the last ninety days. Most recently, Donald J. Steinberg sold 22,500 shares of the business's stock in a transaction on Thursday, June 10th. The shares were sold at an average price of $0.08, for a transaction totalling $1,800.00. Learn More on Donald J. Steinberg's trading history.

Donald J. Steinberg Insider Trading History at Electromedical Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/10/2021Sell22,500$0.08$1,800.00
3/30/2021Sell25,000$0.23$5,750.00
3/12/2021Sell10,000$0.28$2,800.00
2/22/2021Sell14,500$0.40$5,800.00
2/17/2021Sell17,000$0.55$9,350.00
2/11/2021Sell15,600$0.53$8,268.00
2/3/2021Sell11,000$0.42$4,620.00
See Full Table

Donald J. Steinberg Buying and Selling Activity at Electromedical Technologies

This chart shows Donald J Steinberg's buying and selling at Electromedical Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Electromedical Technologies Company Overview

Electromedical Technologies logo
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. The company also develops WellnessPro POD, a compact clinical-grade wearable device for pain management; and Wellness ION Pen, an interferential cold laser used to deliver targeted frequency stimulation to improve circulation and tissue healing, and reduce inflammation and pain. Electromedical Technologies, Inc. was founded in 2002 and is headquartered in Scottsdale, Arizona.
Read More

Today's Range

Now: $0.00
Low: $0.00
High: $0.00

50 Day Range

MA: N/A

2 Week Range

Now: $0.00
Low: $0.00
High: $0.00

Volume

1,573,200 shs

Average Volume

1,582,180 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Tiny Biotech Stock Wins $75 Billion Patent
From Behind the Markets   |   Ad
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>